Innate immune sensing of cancer: clues from an identified role for type I IFNs.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 8, p. 1343, doi. 10.1007/s00262-012-1305-6
- By:
- Publication type:
- Article
Works matching IS 03407004 AND DT 2012 AND VI 61 AND IP 8
Results: 19
1
2
In vivo therapeutic effect of CDH3/P-cadherin-targeting radioimmunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 8, p. 1211, doi. 10.1007/s00262-011-1186-0
- By:
- Publication type:
- Article
3
Rituximab-induced direct inhibition of T-cell activation.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 8, p. 1233, doi. 10.1007/s00262-011-1168-2
- By:
- Publication type:
- Article
4
The expression, function, and clinical relevance of B7 family members in cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 8, p. 1327, doi. 10.1007/s00262-012-1293-6
- By:
- Publication type:
- Article
5
Correlation of HLA-A02* genotype and HLA class I antigen down-regulation with the prognosis of epithelial ovarian cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 8, p. 1243, doi. 10.1007/s00262-012-1201-0
- By:
- Publication type:
- Article
6
FOXP3+ cell density in lymphoid follicles from histologically normal mucosa is a strong prognostic factor in early stage colon cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 8, p. 1183, doi. 10.1007/s00262-011-1191-3
- By:
- Publication type:
- Article
7
Generation of autologous tumor-specific T cells for adoptive transfer based on vaccination, in vitro restimulation and CD3/CD28 dynabead-induced T cell expansion.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 8, p. 1221, doi. 10.1007/s00262-011-1199-8
- By:
- Publication type:
- Article
8
Ex vivo enrichment of circulating anti-tumor T cells from both cutaneous and ocular melanoma patients: clinical implications for adoptive cell transfer therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 8, p. 1169, doi. 10.1007/s00262-011-1179-z
- By:
- Publication type:
- Article
9
Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 8, p. 1191, doi. 10.1007/s00262-011-1196-y
- By:
- Publication type:
- Article
10
Expression of ERp5 and GRP78 on the membrane of chronic lymphocytic leukemia cells: association with soluble MICA shedding.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 8, p. 1201, doi. 10.1007/s00262-011-1195-z
- By:
- Publication type:
- Article
11
Sensitivity of a novel model of mammary cancer stem cell-like cells to TNF-related death pathways.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 8, p. 1255, doi. 10.1007/s00262-012-1200-1
- By:
- Publication type:
- Article
12
CAR T cells transform to trucks: chimeric antigen receptor-redirected T cells engineered to deliver inducible IL-12 modulate the tumour stroma to combat cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 8, p. 1269, doi. 10.1007/s00262-012-1202-z
- By:
- Publication type:
- Article
13
Harnessing human plasmacytoid dendritic cells as professional APCs.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 8, p. 1279, doi. 10.1007/s00262-012-1210-z
- By:
- Publication type:
- Article
14
Eleventh international conference on progress in vaccination against cancer (PIVAC-11), 10-13 October 2011, Copenhagen, Denmark.
- Published in:
- 2012
- By:
- Publication type:
- Report
15
The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 8, p. 1289, doi. 10.1007/s00262-012-1234-4
- By:
- Publication type:
- Article
16
Re-purposing cancer therapeutics for breast cancer immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 8, p. 1299, doi. 10.1007/s00262-012-1247-z
- By:
- Publication type:
- Article
17
TriVax-HPV: an improved peptide-based therapeutic vaccination strategy against human papillomavirus-induced cancers.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 8, p. 1307, doi. 10.1007/s00262-012-1259-8
- By:
- Publication type:
- Article
18
Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC).
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 8, p. 1319, doi. 10.1007/s00262-012-1269-6
- By:
- Publication type:
- Article
19
Neutrophils and granulocytic myeloid-derived suppressor cells: immunophenotyping, cell biology and clinical relevance in human oncology.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 8, p. 1155, doi. 10.1007/s00262-012-1294-5
- By:
- Publication type:
- Article